Mark W Grzanna

Mark W Grzanna

Auto-generated profile, based on publicly available information

Mark W Grzanna

Nutramax Laboratories Veterinary Sciences, Inc, 2208 Lakeside Blvd, Edgewood, MD 21040, USA

Research Focus & Metrics

Academic Career Length

13Years (2014-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2014 in Journal of Inflammation
Verified
Journal Article
Open access
PDF file
SOStacy L Ownby
Stacy L Ownby
LFLowella V Fortuno
Lowella V Fortuno
AAAngela Y Au
Angela Y Au
MGMark W Grzanna
Mark W Grzanna
ARAnn M Rashmir-Raven
Ann M Rashmir-Raven
Carmelita FrondozaCarmelita Frondoza
Carmelita Frondoza
Osteoarthritis (OA) is characterized by inflammation, joint immobility, and pain. Non-pharmacologic agents modulating pro-inflammatory mediator expression offer considerable promise as safe and effective treatments for OA. We previously determined the anti-inflammatory effect of an avocado/soybean unsaponifiables (ASU) and epigallocatechin gallate (EGCG) combination on prostaglandin E2 (PGE2) production and nuclear factor-kappa B (NF-κB) translocation. The aim of this study was to evaluate the effects of ASU + EGCG on pro-inflammatory gene expression.